These findings were consistent across various patient subgroups, including those with metastases at diagnosis and those who developed metastases during follow-up, underscoring the potential significance of FAP as a prognostic marker in ccRCC [65]. Here, FAP is linked to nonpapillary renal cell carcinoma.